APA (7th ed.) Citation

I, R., C, M., E, L., R, C., D, H., EK, H., . . . T, K. (2022). Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. Neurology, 99(17), e1926. https://doi.org/10.1212/WNL.0000000000201029

Chicago Style (17th ed.) Citation

I, Roos, et al. "Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis." Neurology 99, no. 17 (2022): e1926. https://doi.org/10.1212/WNL.0000000000201029.

MLA (9th ed.) Citation

I, Roos, et al. "Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis." Neurology, vol. 99, no. 17, 2022, p. e1926, https://doi.org/10.1212/WNL.0000000000201029.